WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ: 330350)
South Korea
· Delayed Price · Currency is KRW 6,820.00
+20.00 (0.29%)
Dec 27, 2024, 9:00 AM KST
WITHUS PHARMACEUTICAL Co.,LTD. Market Cap
WITHUS PHARMACEUTICAL Co.,LTD. has a market cap or net worth of 92.55 billion as of January 3, 2025. Its market cap has decreased by -41.88% in one year.
Market Cap
92.55B
Enterprise Value
100.91B
Revenue
105.74B
Ranking
n/a
PE Ratio
13.75
Stock Price
6,820.00
Market Cap Chart
Since July 3, 2020, WITHUS PHARMACEUTICAL Co.,LTD.'s market cap has decreased from 302.46B to 92.55B, a decrease of -69.40%. That is a compound annual growth rate of -23.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 3, 2025 | 92.55B | -0.43% |
| Dec 30, 2024 | 92.94B | -27.60% |
| Dec 28, 2023 | 128.37B | 3.84% |
| Dec 29, 2022 | 123.62B | -10.73% |
| Dec 30, 2021 | 138.48B | -26.91% |
| Dec 30, 2020 | 189.48B | -37.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 355.57T |
| SK hynix | 117.96T |
| LG Energy Solution | 80.96T |
| Samsung Biologics Co.,Ltd. | 66.48T |
| Hyundai Motor Company | 52.22T |
| Kia Corporation | 39.59T |
| Celltrion | 39.03T |
| KB Financial Group | 31.23T |